Evaluation of Salivary Il-6, Ifn-Γ and Rage Levels Before and After Topical Betamethasone Nanogel Therapy in Oral Lichen Planus Patients
International Journal of Drug Delivery Technology · 11.06.2026 · 16 (52s)
DOI: 10.25258/ijddt.16.52s.68 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 11.06.2026. Verfasst von Sharan Mann und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Oral lichen planus (OLP) is a chronic immune-mediated inflammatory disorder associated with mucosal pain and functional discomfort. Salivary biomarkers such as IL-6, IFN-γ, and RAGE may reflect disease activity and treatment response. Betamethasone nanogel may improve topical corticosteroid delivery because of its mucoadhesive and sustained-release properties.
Aim
To evaluate salivary IL-6, IFN-γ, and RAGE levels before and after topical betamethasone nanogel therapy in patients with OLP and to assess associated clinical improvement using the Oral Disease Severity Score (ODSS). Materials and Methods: This prospective pre–post interventional study included 10 patients with symptomatic OLP. All patients received topical betamethasone nanogel twice daily for 14 days. Clinical severity was assessed using ODSS at baseline and post-treatment. Unstimulated whole saliva samples were collected at both time points, and salivary IL-6, IFN-γ, and RAGE levels were estimated by ELISA.
Results
All patients completed the study and no adverse effects were observed. Mean ODSS decreased significantly from 6.40 ± 4.45 to 5.00 ± 2.98 (p = 0.0313). Salivary IL-6 decreased from 35.30 ± 0.43 pg/mL to 27.39 ± 0.74 pg/mL, IFN-γ from 56.89 ± 3.30 pg/mL to 35.27 ± 2.67 pg/mL, and RAGE from 357.56 ± 20.40 pg/mL to 274.26 ± 12.26 pg/mL. All biomarker reductions were highly significant (p < 0.001).
Conclusion
Topical betamethasone nanogel resulted in significant clinical and biochemical improvement in OLP. The reduction in ODSS and salivary IL-6, IFN-γ, and RAGE levels suggests that it may be an effective localized antiinflammatory therapy, while salivary biomarkers may serve as useful adjuncts for monitoring treatment response.
Zitieren
APA
Mann, S., & Dharman, S. (2026). Evaluation of Salivary Il-6, Ifn-Γ and Rage Levels Before and After Topical Betamethasone Nanogel Therapy in Oral Lichen Planus Patients. International Journal of Drug Delivery Technology, 16(52s). https://doi.org/10.25258/ijddt.16.52s.68
Vancouver
Mann S, Dharman S. Evaluation of Salivary Il-6, Ifn-Γ and Rage Levels Before and After Topical Betamethasone Nanogel Therapy in Oral Lichen Planus Patients. International Journal of Drug Delivery Technology. 2026;16(52s). doi:10.25258/ijddt.16.52s.68
BibTeX
@article{Mann2026,
author = {Mann, Sharan and Dharman, Sreedevi},
title = {Evaluation of Salivary Il-6, Ifn-Γ and Rage Levels Before and After Topical Betamethasone Nanogel Therapy in Oral Lichen Planus Patients},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {52s},
doi = {10.25258/ijddt.16.52s.68}
}
EUVIMED